First Trust Advisors
INBX icon

First Trust Advisors’s Inhibrx INBX Stock Holding History

First Trust Advisors’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.2M Buy
+128,424
New +$12.9M 0.01% 1135

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

First Trust Advisors's INBX Position: Q2 2026 in Review

First Trust Advisors opened a new position in Inhibrx (INBX) in Q2 2026: 128,424 shares worth $12.2M. The stake represents 0.01% of the portfolio and ranks #1135 among its holdings.

89 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • First Trust Advisors held 128,424 shares of Inhibrx worth $12.2M as of Q2 2026.
  • Inhibrx was a new First Trust Advisors position in Q2 2026.
  • Inhibrx made up 0.01% of First Trust Advisors's portfolio in Q2 2026, its #1135 holding.
  • 89 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.